Phoenix International Life Science Inc. Report issue

For profit Phase 1
Founded: Montreal Canada (1994)
Status: Acquired by MDS Pharma (2000) → now INC Research (2009)

Organization Overview

First Clinical Trial
1994
NCT00913783
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1998

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Phoenix International Life Sciences, Inc.

Active Ingredients

Drugs in Phase 1 Trials (2)

buspirone (buspar) (2 trials)

clomipramine (anafranil) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 1)

Disease (Phase 1)

Malnutrition (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 2